WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its consolidated net loss for the three months ended March 31, 2012 was $9.7 million, or $0.46 per share, compared with net loss of $9.0 million, or $0.44 per share, for the same period in 2011. For full-year 2012, Safeguard projects partner company aggregate revenue in a range of $160 million to $165 million. Results for Safeguard partner companies are reported on a one-quarter lag.
